Mavroides Christopher MD Okeechobee, FL - 34972

Mavroides Christopher MD is categorized under Internal Medicine Doctors in Okeechobee, FL and active since 1989.

Mavroides Christopher MD was established in 1989, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Christopher Mavroides at the company’s single location by writing to 1713 Us Highway 441 North # A, Okeechobee, Florida FL 34972 or by phoning (863) 763-5666. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mavroides Christopher MD
Contact Person: Christopher Mavroides
Address: 1713 Us Highway 441 North # A, Okeechobee, Florida 34972
Phone Number: (863) 763-5666
Annual Revenue (USD): $500.000 to $999.999
Founded: 1989
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Mavroides Christopher MD was started in 1989 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Christopher Mavroides for inquiries that concern Mavroides Christopher MD by calling the company number (863) 763-5666, as your correspondence is most welcome. Additionally, the physical location of the single location of Mavroides Christopher MD can be found at the coordinates 27.26121,-80.82996 as well as the street address 1713 Us Highway 441 North # A in Okeechobee, Florida 34972.

For its online presence, you may visit Mavroides Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.